About

Jillian Hopper is an assistant professor of dance at the University of Michigan School of Music, Theatre & Dance and serves as the Artistic Director of The Dance Legacy Project at Michigan, alongside her creative partner Prof. Christian Matijas-Mecca. She specializes in the dance technique of Doris Humphrey with the goal of preserving this technique for future generations, and she is a Trustee of the Doris Humphrey Foundation in the UK. Hopper's physical practice emphasizes methods of embodiment aimed at increasing empathy and sensitivity in both practice and performance, which has supported her roles as a director of the Dance Legacy Project and as a rehearsal director for the University of Michigan, where she has worked on guest works by notable choreographers such as Ohad Naharin, Richard Alston, Lucinda Childs, Urban Bush Women, Alessio Silvestrin, and Shannon Gillen. She has also taught professionally at institutions including Hillsdale College, Eastern Michigan University, Middlesex University in London, The Place in London, and the Northern School of Contemporary Dance in Leeds. Hopper holds a BA (Hons) in choreography from Middlesex University London and an MFA in Dance Performance from the University of Michigan. Her own choreographic work explores ritualistic movement concepts with an emphasis on nature’s spirituality, and she has performed in works by Monica Bill Barnes, Sidra Bell, Danny T. Reid, Tracy Halloran, and her own compositions across the Midwest and Europe.

Research topics

• Computer Science
• Internal medicine
• Mathematics
• World Wide Web
• Business
• Medical emergency
• Advertising
• Medicine
• Virology

Selected publications

• The Lookout Project: A Student-Run Mail-Based Overdose Response Kit Distribution Program Through Social Media During COVID-19

  PubMed · 2024 · 2 citations

  • Computer Science
  • Advertising
  • Business

  BACKGROUND: Naloxone distribution and overdose education are key preventive strategies to reduce opioid overdose deaths. This paper describes the development and evaluation of The Lookout Project (TLP), a 501(c)(3) organization led by college students and based in Ann Arbor, Michigan. This research aimed to examine the outreach of TLP with hopes of creating a reproducible mail-based kit distribution program for college student-run organizations to replicate. METHODS: TLP used a targeted social media advertising campaign to ask participants 7 multiple-choice questions concerning their demographics, previous incarcerations, experiences with intranasal naloxone (IN), and if they had watched the optional informational video in the opioid overdose response kit (OORK) order form. RESULTS: TLP's team distributed over 900 OORKs from August 3, 2020, to January 4, 2022, first by word of mouth and then through social media advertising that began on February 13, 2021. Of the 657 respondents who agreed to participate in research, the majority identified as white (76.0%, n = 400), did not identify with any specified ethnicity group (60.2%, n = 318), were female (60.8%, n = 356), were between the ages of 18 and 22 (35.4%, n = 209), had not been previously incarcerated (95.6%, n = 564), and did watch the hyperlinked video detailing how to respond to an overdose (74.7%, n = 438). Additionally, several kit recipients (2.8%, n = 19) responded to a follow-up survey. Of those, 7 people reported using the IN provided by TLP to reverse an overdose (36.8%, n = 7). CONCLUSION: TLP, a nonprofit organization founded by college students, shows potential for informing other student-run organizations about naloxone distribution programs using social media advertising.

  PublisherDOI

• Diagnosing Patients and Initiating Treatment

  2018-03-01

  book-chapter

  Abstract Chapter 11 provides an organized approach to diagnosis and to the initial treatment plan, focusing on substance use disorders. The elements of pharmacological and behavioral approaches to treatment, including the management of withdrawal, are addressed separately (Sections III and IV). It begins with directions on initiation of the patient relationship, with the object of eliciting cooperation. The sources of information that should be interrogated are listed, including the history, screening tools, physical examination, laboratory studies, and collateral information (e.g., the prescription drug monitoring program or PDMP). A discussion of diagnosis includes the principles underlying the ICD-10 and the DSM-5. The process of enlisting the patient in a treatment agreement and in the formulation of a collaborative treatment plan is described; the practical elements of patient education in medication accountability and dosing are included. The chapter concludes with a treatment planning checklist to facilitate orderly transition to the treatment itself.

  PublisherDOI

• Revising the Treatment Plan and/or Ending Addiction Treatment

  2018-03-01

  book-chapter1st authorCorresponding

  Abstract Where Chapter 18 discusses revision of the treatment plan and ending of pain treatment, Chapter 23 focuses on the conclusion of addiction treatment. It closes the loop to Chapter 11, Initiating Treatment and Monitoring Patient Progress. The authors describe the conditions which will oblige a revision of the treatment plan; such as alterations in prescription medications with cross-metabolism, pregnancy or menopause, liver disease, or aging. There are also behavioral conditions that will oblige plan modification, whether dysfunctional or hostile behaviors or other psychiatric instability. Consequently, a significant portion of the chapter is dedicated to the identification of relapse, its psychodynamic and developmental meanings, and the appropriate interventions for it. Voluntary and involuntary terminations and the therapeutic steps taken with both are discussed as logical continuations of any treatment plan.

  PublisherDOI

• Reducing Opioid Misuse among Adolescents through Physician Education

  Substance Abuse · 2017-07-19 · 8 citations

  letterSenior author

  Increased prescribing of opioids has been associated with an epidemic of nonmedical prescription opioid use in the United States; adolescents and young adults are particularly vulnerable to opioid misuse. The role of physicians as health care providers, educators, and confidants for their adolescent patients equips them to intervene in adolescent opioid misuse. The authors advocate for improving the education of physicians and residents regarding opioid use and misuse among adolescents. To achieve this, we can require residency education that includes opioid misuse and appropriate prescribing, widely disseminate existing resources on management of pain and opioid misuse, and develop pain management and addiction mentorship programs.

  PublisherDOI

• Implementing the Collaborative Care Model as Part of a Countywide Initiative

  Psychiatric Services · 2016-02-29 · 1 citations

  articleOpen access

  This column describes the planning and implementation of an integrated behavioral health project which was facilitated and endorsed by a developing accountable health community, the Washtenaw Health Initiative (WHI). The WHI is a voluntary countywide coalition of academic, community, health system, and county government agencies dedicated to improving access to high-quality health care for low-income, uninsured, and Medicaid populations. When lack of access to mental health services was identified as a pressing concern, the WHI endorsed pilot testing of collaborative care, an evidence-based treatment model, in county safety-net clinics. Challenges, outcomes, and relevance of this initiative to other counties or regional entities are discussed.

  PublisherOA PDFDOI

• Designer drugs 2015: assessment and management

  Addiction Science & Clinical Practice · 2015-03-11 · 135 citations

  articleOpen access

  Recent designer drugs, also known as "legal highs," include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to as "bath salts"); synthetic cannabinoids (SCs; e.g., Spice); and synthetic hallucinogens (25I-NBOMe, or N-bomb). Compound availability has evolved rapidly to evade legal regulation and detection by routine drug testing. Young adults are the primary users, but trends are changing rapidly; use has become popular among members of the military. Acute toxicity is common and often manifests with a constellation of psychiatric and medical effects, which may be severe (e.g., anxiety, agitation, psychosis, and tachycardia), and multiple deaths have been reported with each of these types of designer drugs. Clinicians should keep designer drugs in mind when evaluating substance use in young adults or in anyone presenting with acute neuropsychiatric complaints. Treatment of acute intoxication involves supportive care targeting manifesting signs and symptoms. Long-term treatment of designer drug use disorder can be challenging and is complicated by a lack of evidence to guide treatment.

  PublisherOA PDFDOI

• Isolated shoulder weakness as a result of a cortical infarction in the precentral gyrus

  Journal of Community Hospital Internal Medicine Perspectives · 2015-01-01 · 2 citations

  articleOpen accessSenior author

  Since its discovery, our understanding of the primary motor cortex has continued to evolve. The presentations of rare, isolated, motor palsies of small muscle groups have heavily contributed to the characterization of the somatotopic representation of the human body on the cortex. We present a case of localized, left shoulder small muscle group weakness secondary to ischemic cerebral infarction in the primary motor cortex. The patient experienced full recovery over several days. Strokes causing isolated shoulder weakness are rare due to the relatively small area dedicated to shoulder motor function in the precentral gyrus. However, our patient presented with a larger area of infarction than in previously reported cases, demonstrating the large individual variability that may exist within the motor cortex somatotopic map.

  PublisherOA PDFDOI

• A multifactorial intervention for hospital opioid management

  Journal of Opioid Management · 2014-09-01 · 3 citations

  articleSenior author

  OBJECTIVE: To determine whether an educational intervention combined with a voluntary decision support system improves inpatient pain control. DESIGN: Retrospective serial cross-sectional study. SETTING: Community teaching hospital. PATIENTS: Patients admitted to internal medicine teaching service from October to December 2011 and 2012. The study cohorts consisted of a random sample of 75 patients each from both time periods. INTERVENTIONS: Beginning in August 2012, internal medicine residents participated in an interactive training session on the use of opioids for hospitalized patients and concurrently, a user initiated voluntary computerized decision support system (CDSS), in the form of computer order entry (COE) and pocket cards were introduced. The COE options correspond to the standardized opioid dosing regimen on the pocket card. Pain scores and opioid doses and demographic information were obtained from administrative databases. Additional covariates were abstracted via programmed electronic medical record (EMR) review. MAIN OUTCOME MEASURES: Pre- and postintervention, maximum reported pain score in every 8-hour period from first analgesic dose, to 72 hours after the first analgesic dose, were compared by fitting a multivariable linear mixed model. Naloxone use was a surrogate measure for secondary outcome of opioid overdose. RESULTS: The intervention had no effect on maximum pain score (MPS) over time, p = 0.0930. The estimated mean MPS (95% confidence interval) was 4.7 (3.9, 5.5) preintervention and 5.2 (4.4, 6.0) postintervention. CONCLUSIONS: A combination of a resident educational intervention, CDSS, and pocket cards did not improve MPSs over time for patients on an internal medicine teaching service.

  PublisherDOI

• A Randomized Trial of Computer-Delivered Brief Intervention and Low-Intensity Contingency Management for Smoking During Pregnancy

  Nicotine & Tobacco Research · 2011-12-09 · 84 citations

  articleOpen accessSenior author

  INTRODUCTION: Implementation of evidence-based interventions for smoking during pregnancy is challenging. We developed 2 highly replicable interventions for smoking during pregnancy: (a) a computer-delivered 5As-based brief intervention (CD-5As) and (b) a computer-assisted, simplified, and low-intensity contingency management (CM-Lite). METHODS: A sample of 110 primarily Black pregnant women reporting smoking in the past week were recruited from prenatal care clinics and randomly assigned to CD-5As (n = 26), CM-Lite (n = 28), CD-5As plus CM-Lite (n = 30), or treatment as usual (n = 26). Self-report of smoking, urine cotinine, and breath CO were measured 10 weeks following randomization. RESULTS: Participants rated both interventions highly (e.g., 87.5% of CD-5As participants reported increases in likelihood of quitting), but most CM-Lite participants did not initiate reinforcement sessions and did not show increased abstinence. CD-5As led to increased abstinence as measured by cotinine (43.5% cotinine negative vs. 17.4%; odds ratio [OR] = 10.1, p = .02) but not for CO-confirmed 7-day point prevalence (30.4% abstinent vs. 8.7%; OR = 5.7, p = .06). Collapsing across CM-Lite status, participants receiving the CD-5As intervention were more likely to talk to a doctor or nurse about their smoking (60.5% vs. 30.8%; OR = 3.0, p = .02). CONCLUSIONS: Low-intensity participant-initiated CM did not affect smoking in this sample, but the CD-5As intervention was successful in increasing abstinence during pregnancy. Further research should seek to replicate these results in larger and more diverse samples. Should CD-5As continue to prove efficacious, it could greatly increase the proportion of pregnant smokers who receive an evidence-based brief intervention.

  PublisherOA PDFDOI

• lifepool: A collaboration between Women and Researchers

  eCite Digital Repository (University of Tasmania) · 2011-01-01 · 1 citations

  article

  lifepool is a large prospective cohort of women on whom health and lifestyle information, mammogram results and health outcome data will be gathered. A subset of participants will provide biospecimens. lifepool will support research into breast cancer and aims to recruit 100,000 women.

  Publisher

Frequent coauthors

• Ashley A. Wiedemann

  Yale University

  27 shared

• Karen K. Saules

  27 shared

• Valentina Ivezaj

  Yale University

  27 shared

• Anne Eshelman

  Henry Ford Health System

  25 shared

• Daniel W. Wood

  25 shared

• Brent C. Williams

  4 shared

• D. Edward Deneke

  4 shared

• Marianne Udow‐Phillips

  E Ink (South Korea)

  4 shared

Education

• MD

  Wayne State University School of Medicine

  1989